A new nanodiamond-based dual-mode contrast agent provides clearer and more accurate images of liver tumors at lower dosages, report researchers.
A new nanodiamond-based dual-mode contrast agent provides clearer and more accurate images of liver tumors at lower dosages, report researchers.